نتایج جستجو برای: non alcoholic fatty liver disease nafld
تعداد نتایج: 2934139 فیلتر نتایج به سال:
Background and purpose: Non-alcoholic fatty liver syndrome have high prevalence in Iran. Non-alcoholic fatty liver disease (NAFLD) includes clinical spectrum from simple steatosis to cirrhosis and liver carcinoma. In advanced stages NAFLD has irreversible complications, therefore early treatments especially with medicinal plants can be considered as an important strategy in its treatment. This ...
The problems among obesity, diabetes mellitus (DM), fatty liver, metabolic dysfunction have been prevalent, and diagnostic criteria as non-alcoholic liver disease (NAFLD) has used in practice. When diagnosing NAFLD, to exclude other related diseases was necessary, including excessive alcohol intake. international experts proposed the proper term from NAFLD associated (MAFLD). MAFLD include evid...
background a strong association between obesity and non-alcoholic fatty liver disease (nafld) has been reported. objectives this study was conducted to evaluate if new obesity indices, including a body shape index (absi) and body roundness index (bri), have stronger associations with nafld than waist-to-hip ratio (whr) and waist-to-height ratio (whtr). methods in this cross-sectional study, we ...
nonalcoholic fatty liver disease (nafld) is an obesity-associated disease and dysregulation of adipokines has an important role in its development. omentin-1 (itln1 protein) and resistin are two adipokine secreted from adipose tissue. single nucleotide polymorphisms in the adipokine genes may affect expression and activity of the adipokine, and thus play a contributory role in nafld pathogenesi...
Non-alcoholic fatty liver disease (NAFLD) is the term used to describe the alcohol-like liver injury that occurs in the absence of alcohol abuse. It involves a range of histological abnormalities including simple steatosis or fatty liver, non-alcoholic steatohepatitis (NASH) and NAFLD induced cirrhosis. The predominant risk factor for NAFLD appears to be insulin resistance. Simple steatosis and...
Context: Considering the increasing prevalence of obesity and insulin resistance syndrome worldwide, non-alcoholic fatty liver disease (NAFLD) has become a major health concern. Early diagnosis and proper management might prevent disease progression. The aim of this article is to review the current knowledge on the diagnosis and evaluation of disease severity in NAFLD. Evidence Acquisition: Aft...
Background: Non-alcoholic fatty liver disease is one of the most important chronic liver disorders worldwide. Adipokines are polypeptide hormones that participate in the pathogenesis of non-alcoholic fatty liver disease. Adiponectin is an adipokine that stimulates fatty acid oxidation in muscle and plays a role in the development of insulin sensitivity. This study aimed to investigate the assoc...
BACKGROUND Non-alcoholic fatty liver disease (NAFLD) is considered to be the commonest liver problem in the western world and is increasingly being recognised as a major cause of liver-related morbidity and mortality. It is known to be associated with various metabolic abnormalities, but not much information regarding association between the metabolic disease and the severity of fatty liver is ...
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, and the prevalence of non-alcoholic steatohepatitis (NASH) with fibrosis is increasing as the population with NAFLD ages. To date, lifestyle modifications including weight loss, increased physical activity, and dietary changes remain the treatment of choice for NAFLD because there are no approved effective pharm...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید